RecallRadar

FDA Drug recall D-0379-2021

Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10

On 2021-05-26 the FDA classified a Class III recall of Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10 by Sigmapharm Laboratories, citing incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0379-2021
ClassificationClass III
Statusterminated
Initiated2021-04-19
Published2021-05-26
Last updated2026-09-13 11:52 UTC
CompanySigmapharm Laboratories
DistributionUS

Product

Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10.

Reason

Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

Identifiers

ndc42794-016-22
ndc42794-016-08
ndc42794-016-10
ndc42794-017-22
ndc42794-017-08
ndc42794-017-10
code_infoLots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0379-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.